GATTICCHI, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 457
EU - Europa 325
AS - Asia 180
Totale 962
Nazione #
US - Stati Uniti d'America 456
IT - Italia 120
IE - Irlanda 105
SG - Singapore 64
HK - Hong Kong 48
CN - Cina 41
DE - Germania 20
FR - Francia 16
RO - Romania 16
VN - Vietnam 14
FI - Finlandia 12
RU - Federazione Russa 11
BE - Belgio 9
KR - Corea 4
GB - Regno Unito 3
JP - Giappone 3
NL - Olanda 3
UA - Ucraina 3
AT - Austria 2
CH - Svizzera 2
TW - Taiwan 2
CZ - Repubblica Ceca 1
IR - Iran 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PL - Polonia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 962
Città #
Chandler 134
Dublin 105
Perugia 50
Hong Kong 48
Singapore 46
Ann Arbor 31
San Mateo 31
Altamura 27
Boardman 27
Beijing 22
Bucharest 16
Medford 16
Princeton 16
Des Moines 15
Lawrence 15
Dong Ket 14
Wilmington 13
Redmond 12
Ashburn 9
Brussels 9
Redwood City 9
Los Angeles 8
Andover 6
Falls Church 6
Camerino 5
Saint Petersburg 5
Assisi 4
Munich 4
New York 4
Seoul 4
Turin 4
Dallas 3
Helsinki 3
Osaka 3
Pioltello 3
Bologna 2
Colle di Val d'Elsa 2
Den Haag 2
Foligno 2
Kaohsiung 2
Lappeenranta 2
Menlo Park 2
Milan 2
Monreale 2
Santa Clara 2
Santarcangelo di Romagna 2
Bergen 1
Boydton 1
Brno 1
Corciano 1
Esslingen am Neckar 1
Fairfield 1
Groningen 1
Gunzenhausen 1
Izmir 1
Kiev 1
Kish 1
La Canada Flintridge 1
Lausanne 1
Marcallo con Casone 1
Norwalk 1
San Paolo di Civitate 1
Selargius 1
Siena 1
Spoleto 1
Terni 1
Woodbridge 1
Zhengzhou 1
Totale 771
Nome #
Selected cholesterol biosynthesis inhibitors produce accumulation of the intermediate FF-MAS that targets nucleus and activates LXRα in HepG2 cells 91
Palmitate lipotoxicity in enteric glial cells: Lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria 82
Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways 70
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 69
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 64
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 63
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 59
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 57
Tm7sf2 gene promotes adipocyte differentiation of mouse embryonic fibroblasts and improves insulin sensitivity 53
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis 51
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells. 49
The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells 49
A novel role for Tm7sf2 gene in regulating TNFα expression. 48
Palmitate lipotoxicity in enteric glial cells 45
The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury 43
The loss of Tm7sf gene accelerates skin papilloma formation in mice 42
Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach 40
Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1 28
CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1 20
Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities 5
Totale 1.028
Categoria #
all - tutte 4.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202045 0 0 0 0 1 0 15 2 6 14 7 0
2020/202185 3 0 0 3 29 2 16 2 0 11 1 18
2021/2022186 6 25 0 3 2 19 5 34 5 45 20 22
2022/2023381 19 64 10 36 36 43 2 23 136 0 11 1
2023/2024181 23 13 9 3 10 1 45 11 8 10 26 22
2024/202583 11 31 7 28 6 0 0 0 0 0 0 0
Totale 1.028